Biopharma IPO Interest Peaks Following Strong Reception
institutionalinvestor.com/article/2edj7fq5bgg4qc2a9gl4w/premium/biopharma-ipo-interest-peaks-following-strong-reception
A dozen hedge funds, including Perceptive, Farallon, and Marshall Wace, will benefit from companies that either went public or filed plans in the past few days.
This story appeared on institutionalinvestor.com, 2025-02-04 15:40:57.